133 related articles for article (PubMed ID: 37356600)
1. CEST 2022-three-dimensional amide proton transfer (APT) imaging can identify the changes of cerebral cortex in Parkinson's disease.
Tian Y; Li X; Wang X; Su W; Li S; Wang W; Zhang Y; Li C; Chen M
Magn Reson Imaging; 2023 Oct; 102():235-241. PubMed ID: 37356600
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of low- and high-grade pediatric gliomas with amide proton transfer imaging: added value beyond quantitative relaxation times.
Zhang H; Yong X; Ma X; Zhao J; Shen Z; Chen X; Tian F; Chen W; Wu D; Zhang Y
Eur Radiol; 2021 Dec; 31(12):9110-9119. PubMed ID: 34047848
[TBL] [Abstract][Full Text] [Related]
3. Amide proton transfer (APT) imaging of brain tumors at 7 T: The role of tissue water T
Khlebnikov V; Polders D; Hendrikse J; Robe PA; Voormolen EH; Luijten PR; Klomp DW; Hoogduin H
Magn Reson Med; 2017 Apr; 77(4):1525-1532. PubMed ID: 27060863
[TBL] [Abstract][Full Text] [Related]
4. 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.
Wu Y; Wood TC; Arzanforoosh F; Hernandez-Tamames JA; Barker GJ; Smits M; Warnert EAH
MAGMA; 2022 Feb; 35(1):63-73. PubMed ID: 34994858
[TBL] [Abstract][Full Text] [Related]
5. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
Kroh F; von Knebel Doeberitz N; Breitling J; Maksimovic S; König L; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Magn Reson Med; 2023 Oct; 90(4):1569-1581. PubMed ID: 37317562
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of quantitative metrics in chemical exchange saturation transfer imaging for grading gliomas in adults.
Liu R; Wang X; Zhao Z; Wen Q; Liu T; Wu D; Wen Z; Zhang Y
Magn Reson Imaging; 2023 Feb; 96():50-59. PubMed ID: 36403863
[TBL] [Abstract][Full Text] [Related]
8. Systematic Evaluation of Amide Proton Chemical Exchange Saturation Transfer at 3 T: Effects of Protein Concentration, pH, and Acquisition Parameters.
Schmidt H; Schwenzer NF; Gatidis S; Küstner T; Nikolaou K; Schick F; Martirosian P
Invest Radiol; 2016 Oct; 51(10):635-46. PubMed ID: 27272542
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the effects of water proton concentration and water T
Lee DH; Heo HY; Zhang K; Zhang Y; Jiang S; Zhao X; Zhou J
Magn Reson Med; 2017 Feb; 77(2):855-863. PubMed ID: 26841096
[TBL] [Abstract][Full Text] [Related]
10. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
11. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of hemangioblastoma from brain metastasis using MR amide proton transfer imaging.
Kamimura K; Nakajo M; Gohara M; Kawaji K; Bohara M; Fukukura Y; Uchida H; Tabata K; Iwanaga T; Akamine Y; Keupp J; Fukami T; Yoshiura T
J Neuroimaging; 2022 Sep; 32(5):920-929. PubMed ID: 35731178
[TBL] [Abstract][Full Text] [Related]
13. Amide proton transfer imaging of brain tumors using a self-corrected 3D fast spin-echo dixon method: Comparison With separate B
Togao O; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Yoneyama M; Honda H
Magn Reson Med; 2017 Jun; 77(6):2272-2279. PubMed ID: 27385636
[TBL] [Abstract][Full Text] [Related]
14. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
[TBL] [Abstract][Full Text] [Related]
15. Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma.
Park KJ; Kim HS; Park JE; Shim WH; Kim SJ; Smith SA
Eur Radiol; 2016 Dec; 26(12):4390-4403. PubMed ID: 26883333
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners.
Wu Y; Wood TC; Derks SHAE; Pruis IJ; van der Voort S; van Zanten SEMV; Smits M; Warnert EAH
Sci Rep; 2023 Oct; 13(1):18115. PubMed ID: 37872418
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of renal function in chronic kidney disease (CKD) by mDIXON-Quant and Amide Proton Transfer weighted (APTw) imaging.
Ju Y; Wang Y; Luo RN; Wang N; Wang JZ; Lin LJ; Song QW; Liu AL
Magn Reson Imaging; 2023 Nov; 103():102-108. PubMed ID: 37451519
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma.
Wamelink IJHG; Kuijer JPA; Padrela BE; Zhang Y; Barkhof F; Mutsaerts HJMM; Petr J; van de Giessen E; Keil VC
J Magn Reson Imaging; 2023 Jan; 57(1):206-215. PubMed ID: 35633282
[TBL] [Abstract][Full Text] [Related]
20. Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease.
He N; Ghassaban K; Huang P; Jokar M; Wang Y; Cheng Z; Jin Z; Li Y; Sethi SK; He Y; Chen Y; Gharabaghi S; Chen S; Yan F; Haacke EM
Neuroimage; 2021 Apr; 230():117810. PubMed ID: 33524572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
